Antianginal Drug Therapy for Silent Myocardial Ischemia
- 1 January 1988
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 72 (1) , 185-196
- https://doi.org/10.1016/s0025-7125(16)30789-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of beta blockade on silent regional left ventricular wall motion abnormalitiesThe American Journal of Cardiology, 1986
- Silent myocardial ischemia: dimensions of the problem in patients with and without anginaThe American Journal of Medicine, 1986
- Platelets and antiplatelet therapy in ischemic heart diseaseCurrent Problems in Cardiology, 1986
- Clinical evaluation of transient myocardial ischemia during daily lifeThe American Journal of Medicine, 1985
- Transient ST-segment depression as a marker of myocardial ischemia during daily lifeThe American Journal of Cardiology, 1984
- Rationale for the choice of calcium antagonists in chronic stable angina: An objective double-blind placebo-controlled comparison of niffedipine and verapamilThe American Journal of Cardiology, 1982
- Calcium channel blockade as primary therapy for stable angina pectoris: A double-blind placebo-controlled comparison of verapamil and propranololThe American Journal of Cardiology, 1982
- Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.Circulation, 1982
- Nifedipine and propranolol: A beneficial drug interactionThe American Journal of Medicine, 1981
- Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate: A double crossover study in a coronary care unitThe American Journal of Cardiology, 1979